116 related articles for article (PubMed ID: 19699016)
1. What is the significance of monoclonal gammopathy of undetermined significance?
Atkin C; Richter A; Sapey E
Clin Med (Lond); 2018 Oct; 18(5):391-396. PubMed ID: 30287433
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.
Xu A; Guo T; Zhang S; Luo H; Shen M; Ye Y; Ji L
Hematology; 2024 Dec; 29(1):2352686. PubMed ID: 38819332
[TBL] [Abstract][Full Text] [Related]
3. Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy.
Liu GY; Tang O; Brotman DJ; Miller ER; Moliterno AR; Juraschek SP
PLoS One; 2020; 15(1):e0224977. PubMed ID: 31940353
[TBL] [Abstract][Full Text] [Related]
4. A Case Report: Monoclonal Gammopathy of Undetermined Significance Presenting With Renal Amyloidosis and Reactive Thrombocytosis.
Theik NWY
Cureus; 2024 May; 16(5):e59580. PubMed ID: 38826891
[TBL] [Abstract][Full Text] [Related]
5. A Unique Case of Cellulitis Secondary to Mycobacterium chelonae in a Patient With Monoclonal Gammopathy of Undetermined Significance.
Oluic S; Hassan M; El Labban M; Guleid H; Wedzina W
Cureus; 2024 Apr; 16(4):e57514. PubMed ID: 38572178
[TBL] [Abstract][Full Text] [Related]
6. The Global Reading Room: Imaging in Monoclonal Gammopathy of Undetermined Significance.
Chang CY; Jung JY; Moulopoulos LA; Wennmann M
AJR Am J Roentgenol; 2024 May; ():. PubMed ID: 38775437
[No Abstract] [Full Text] [Related]
7. Introducing the 'Significance' box in Trends in Immunology articles.
Sacristán C
Trends Immunol; 2022 Nov; 43(11):849-850. PubMed ID: 36216718
[No Abstract] [Full Text] [Related]
8. Disentangling age, gender, and racial/ethnic disparities in multiple myeloma burden: a modeling study.
Huber JH; Ji M; Shih YH; Wang M; Colditz G; Chang SH
Nat Commun; 2023 Sep; 14(1):5768. PubMed ID: 37730703
[TBL] [Abstract][Full Text] [Related]
9. Imaging for Plasma Cell Dyscrasias: What, When, and How?
Guha A; Vijan A; Agarwal U; Goda JS; Mahajan A; Shetty N; Khattry N
Front Oncol; 2022; 12():825394. PubMed ID: 35402253
[TBL] [Abstract][Full Text] [Related]
10. Incidental finding of monoclonal gammopathy in blood donors: a follow-up study.
La Raja M; Barcobello M; Bet N; Dolfini P; Florean M; Tomasella F; De Angelis V; Mascaretti L
Blood Transfus; 2012 Jul; 10(3):338-43. PubMed ID: 22507857
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
Stelmach-Gołdyś A; Czarkowska-Paczek B
Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathies of undetermined significance.
Kyle RA; Rajkumar SV
Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
[TBL] [Abstract][Full Text] [Related]
14. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
Madan S; Greipp PR
Blood Rev; 2009 Nov; 23(6):257-65. PubMed ID: 19699016
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Br J Haematol; 2006 Sep; 134(6):573-89. PubMed ID: 16938117
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
Kyle RA; Rajkumar SV
Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
